tumor necrosis factor (TNF), and platelet-derived growth factor. Some of these signals induce IL-6 effectively only in one cell type, and this selectivity of induction may explain selectivity of biologic effects. In the present study, we show that IL-18. previously known to be a potent inducer of IL-6 in fibroblasts, endothelial cells, and keratinocytes, but not in monocytes, is also a potent inducer of IL-6 in peripheral blood monocytes. High level IL-6 activity that could be neutralized by specific antibodies to IL-6 was detected in supernatants of IL-I -stimulated monocytes. Maximal induction required IL-1 concentrations of 10 ng/mL. As judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis under reducing conditions, IL-6 ULTIPLICITY OF targets and multiplicity of bio-M logic effects are common features among cytokines.
Interleukin-6 (IL-6), one of the most pleiotropic and promiscuous of cytokines, has been reported to regulate the synthesis of many acute phase plasma proteins in liver cells,' to promote growth and immunoglobulin (Ig) secretion in B cells infected with Epstein-Barr virus (EBV):3 and to act as an accessory signal for mitogen costimulated T cells!vs IL-6 has also been reported to have antiviral to support colony formation by hematopoietic progenitor cells,' to act as a growth factor for certain mouse B-cell hybridomas and plasmacytomas,9-" to serve as a differentiation factor for the development of cytolytic T cells,12 to synergize with IL-1 in the stimulation of thymocyte pr~liferation,'~ and to serve as a growth factor for human plasmacytoma^.'^^'^ Many of the biologic activities attributed to IL-6 have also been attributed to other cytokines, to hematopoietic colony stimulating factors, to interferons, and to tumor necrosis factor (TNF). In particular, IL-1 displays a number of the biologic activities of IL-6, such as regulation of growth and differentiation of cells in the immune and hematopoietic systems, and modulation of acute phase responses. I6 To begin to separate the spectrum of activities of IL-1 from those of IL-6, it is important to distinguish between direct IL-1 effects, which derive from an interaction of this ligand with a specific target, and indirect effects, which derive from induction of secondary cytokines.
It is well-established that IL-1 is a potent inducer of IL-6 in fibroblasts, endothelial cells, and keratin~cytes.'~-'~ In contrast, it is not clear whether IL-1 induces IL-6 production in monocytes. Separate studies of this issue have reported both that IL-1 is a poor inducer," a noninducer,2' or a good inducer2' of IL-6 activity or IL-6 gene expression.
Peripheral blood monocytes are stimulated to produce IL-6 by a variety of signals and are exquisitely sensitive to bacterial lipopolysaccharide (for a review, see reference 21). Therefore, it is possible that differences in culture conditions and/or lipopolysaccharide (LPS) contamination of the IL-1 preparation used might explain differences in results.
In the present study, we show that under the culture conditions used, monocytes fail to secrete IL-6 spontaneously. Addition of purified preparations of recombinant, LPS-free, IL-1j3 to these cells causes high level IL-6 production. Thus, IL-1, previously known to induce IL-6 in fibroblasts, endothelial cells, and keratino~ytes,'~"~ is also a potent inducer of IL-6 in human monocytes.
MATERIALS AND METHODS
Peripheral blood mononuclear cells (PBMC) were obtained by density centrifugation of normal peripheral blood. Monocyte-enriched populations were obtained by plastic adherence of PBMC during 1.5-hour incubation at 37OC, and contained 78% to 82% monocytes as determined by staining with nonspecific esterase.'' In selected experiments, monocytes were further purified by elutriation of PBMC, and contained 90% to 95% nonspecific esterase positive cells.24 Lymphoblastoid cell lines were obtained by EBV (B95-8) immortalization of peripheral blood B cellsF5 The IL-Mependent murine hybridoma cell line B926 was a gift of Dr R. Nordan (NIH, Bethesda, MD).
Highly purified, Escherichia coli-derived IL-lj3 (a gift of Dr Y. Hirai, Otsuka Pharmaceutical Co, Tokushima, Japan) had a specific activity of approximately 1 x lo7 Units/mg pr~tein.'~ One unit of IL-1 is defined as the amount required for half-maximal costimulation of mouse thymocytes. LPS from E coli 0127:BS was purchased from Sigma Chemical Co, St Louis, MO. A previously characterized" rabbit 1306 TOSATO AND JONES antiserum to purified E coli-derived IL-6 (a gift of Drs L. May and P. Sehgal, Rockefeller University, NY) was purified using protein A-Sepharose. A previously ~haracterized~~ rabbit antiserum to purified recombinant human IL-IS (R290; a gift of Drs R. Newton and J. Giri, DuPont Glenolden Lab, Glenolden, PA) was purified using protein A-Sepharose. Normal rabbit serum was purified using protein A-Sepharose.
Cell cultures for IL-6 production and assay for IL-6 activity. Culture medium for IL-6 production consisted of Opti-MEM (GIBCO Laboratories, Grand Island, NY) supplemented with mol/L 2ME and 5 pg/mL gentamicin (Sigma). PBMC, suspended in Opti-MEM (15 x lo7 cells in 5 mL) were incubated in tissue culture flasks (25 cm2; Costar, Cambridge, MA) for 1.5 hours at 37OC in a humidified atmosphere containing 5% CO,. After incubation, nonadherent cells were vigorously removed, 5 cc of culture medium was added to the adherent cells, and flasks were incubated for an additional 24 hours. At the end of culture, cell-free culture supernatants were supplemented with Aprotinin (10 pg/mL, Sigma) and frozen at -2OOC.
Monocyte-enriched (90% to 95% nonspecific esterase positive cells) cells, monocyte-depleted (less than 3% nonspecific esterase positive cells) cells, and PBMC obtained by elutriation were incubated (30 x lo6 cells in 5 mL Opti-MEM) for 24 hours at 37OC in a humidified atmosphere containing 5% CO,. At the end of culture, cell-free supernatants were harvested and stored as described above.
IL-6 in culture supernatants was quantitated by its ability to support the growth of the IL-64ependent hybridoma cell line, B9.26 Briefly, 2 x lo3 exponentially growing B9 cells in 0.1 mL medium consisting of RPMI 1640 (Biofluids, Rockville, MD) supplemented with 20% fetal calf serum (FCS, Reheis, Armour Pharmaceutical Co, Kankakee, IL), 2 mmol/L L-glutamine (GIBCO), 5 pg/mL gentamicin (Sigma), and 2 x mol/L 2ME were incubated in 96 well flat-bottom plates (Costar) for 3 days with the addition of 100 pL of either control medium or serial dilutions of test supernatants. At the end of culture, cell proliferation was measured by [3H]thymidine (net 027; New England Nuclear, Boston, MA; specific activity 6.7 Ci/mmol/L) incorporation during an 18-hour incubation at a final concentration of 0.5 pCi per culture. Proliferation was expressed as mean cpm of triplicate cultures. One unit of IL-6 is defined as the amount required for induction of one-half maximal stimulation of proliferation of B9 cells. IL-6 was also measured by its ability to promote the growth of EBV-infected lymphoblastoid cells cultured at low density, as described?
Radiolabeling, immunoprecipitation, and polyacrylamide gel electrophoresis. Monocyte-enriched populations, obtained by plastic adherence (1.5 hour on 25 cm2 tissue culture flasks) of 15 x IO6 PBMC in 5 mL methionine-deficient MEM (GIBCO) with 1% heat-inactivated dialyzed FCS (Reheis Armour Pharmaceutical), and 2 mmol/L L-glutamine were cultured in the same medium ( 5 mL) with 100 pCi/mL %methionine (New England Nuclear; 1,000 Ci/mmol). At the end of culture, cell-free supernatants were mixed with a saturated solution of ammonium sulfate (50% vol/vol) and the resulting precipitates were suspended in 0.25 mL Trisbuffered saline (PBS; 25 mmol/L Tris, pH 7.4) containing 2 mmol/L phenylmethylsulfonyl fluoride (PMSF) and 150 pg/mL L-1-tosylamido-2-phenylethyl-chloromethyl ketone (TPCK). The immunoprecipitation was performed essentially as described.24 An aliquot (100 pL) of labeled precipitate that had been precleared using 100 pL of a 10% (wt/vol) suspension of heat-killed and formalin-treated Staphylococcus aureus Cowan strain 1 (Calbiochem, La Jolla, CA), was incubated for 18 hours at 4OC with 1 pL or either a control normal rabbit serum on an antiserum to purified E coli-derived IL-6 (a gift of Drs L. May and P. Sehgal). A total of 100 pL of the 10% (wt/vol) S aureus preparation was then added, and after 45 minutes incubation at 4OC, the bacteria were pelletted and washed three times with a cold (4OC) immunoprecipitation buffer (PBS, 25 mM Tris, pH 7.4, 1% Triton X-100,2 mmol/L PMSF, 150 pg/mL TPCK, and 2.5 mol/L KCI). After two additional washes with isotonic immunoprecipitation buffer at 4OC, the pellets were suspended in 40 pL of 2x gel sample buffer (0.125 mol/L Tris, pH 6.8, 4% sodium dodecyl sulfate (SDS), 10% 2ME, 20% glycerol) boiled 2 minutes, centrifuged, and then electrophoresed through a 12.5% polyacrylamide gel containing 0.1% SDS." After electrophoresis, the gel was fixed, fluorographed by treating with Enlightening (New England Nuclear), dried and autoradiographed at -7OOC.
RESULTS
To investigate IL-1 induction of IL-6 in monocytes, we selected a preparation of E coli-derived IL-lp (Otsuka Pharmaceutical) that was found to have a very low content of LPS. In three separate testings, this IL-1 preparation a t the concentration of 1 mg/mL, contained equal to or less than 2.5 endotoxin Units/mL, as determined by the Limulus assay.30 This corresponds to a content of LPS not greater than 250 pg/mg of IL-1 and, in each determination, the diluent in which IL-1 was suspended, 0-MEM, was found to contain an equal or slightly higher amount of LPS.
As a source of monocytes we used plastic adherent PBMC that contained 79% to 82% nonspecific esterase-positive cells. Monocyte-enriched populations were incubated for 24 hours in serum-free culture medium (0-MEM) alone or supplemented with either LPS (1 pg/mL) or recombinant IL-lp (100 ng/mL). At the end of culture, the filtered (0.45 p ) supernatants were tested for IL-6 activity using the IL-6-dependent hybridoma cell line, B9.26 As shown in representative experiments (Table l) , while unstimulated cell culture supernatants contained low level IL-6 activity, both LPS and IL-1 stimulated culture supernatants contained large and comparable levels of IL-6 activity. It should be noted that previous experiments had shown that the dose of LPS used, 1 pg/mL, induced maximal IL-6 release in plastic adherent PBMC.24 It should also be noted that control media supplemented with LPS (1 pg/mL) or IL-1 (100 ng/ml) run in parallel had no detectable IL-6 activity (not shown).
Production of IL-6 activity in monocyte-enriched populations was dependent upon the dose of IL-1 used. As shown in Fig 1, maximal IL-6 activity was induced by IL-1 at concentrations of 10 ng/mL. This finding indicates that For optimal induction of IL-6 activity in monocyte-enriched populations is observed at IL-1 concentrations similar to those required for IL-6 induction in fibroblasts and endothelial cell^.'^^^' Among PBMC, monocytes are known to represent the major cellular source of IL-6.26 It was possible, however, that contaminating lymphocytes contributed to IL-6 activity production. To address this possibility, we further purified PBMC by elutriation to achieve a cell population containing greater than 95% monocytes (nonspecific esterase positive cells). A comparison between IL-6 activity produced in mononuclear cells enriched and depleted of monocytes (containing 3% nonspecific esterase-positive cells) showed that only negligible levels of IL-6 activity were induced by IL-lB in monocyte-depleted populations when compared with monocyte-enriched populations (Table 2 ). This finding demonstrates that monocytes are the source of IL-6 activity upon stimulation with IL-1p.
Although the hybridoma cell line B9 has been reported to be IL-6-specific, and not to proliferate in response to other known growth factors,26 it is possible that molecules other than IL-6 might induce it to proliferate. To ensure that IL-6, induced by IL-1 in monocytes, was the molecule responsible for growth of B9 cells, we performed neutralization experiments. As shown in Fig 2, unlike a control rabbit IgG, an antibody to E coli-derived IL-628 neutralized the growth promoting activity of an IL-1-induced monocyte supernatant in a dose-dependent manner. Monocyte-enriched (greater than 95% nonspecific esterase-positive cells) and monocyte-depleted (2% nonspecific esterase-positive cells) PBMC obtained by elutriation of PBMC were cultured (30 x 10' cells in 5 mL 0-MEM) for 24 hours. Cell-free supernatants of 24-hour monocyte cultures were tested for IL-6 content using the IL-6-dependent cell line, 69. Results are expressed as 11-6 units/mL in cell-free culture supernatants.
Similar to LPS-induced monocyte supernatants, IL-1-induced monocyte supernatants promoted growth in EBVimmortalized B cells, a property previously attributed to IL-6 ( Table 3) .'2*24 This B cell stimulatory function was also neutralized by anti-IL-6 antibodies (data not shown).
To further establish that IL-6 is induced in IL-1-stimulated monocytes, we tested whether it could be immunoprecipitated from these supernatants. As shown in Fig (Fig 3A. lane 3) . Ry contrast. control supernatants of monocytes cultured in medium alone contained little immunoprccipitable 11.4 (Fig 3A. lane I) . Taken together. these mults confirm that 11.-1 induces IL-6 secretion in monocytes. and indicate that the induccd lb-6 is heterogenous in s i x . Heterogeneity is a reported property of human 11.4 produced in a variety of cell t y p . ' ' Indeed. supernatants of 1.W-stimulated monocytes. rated in paralIcl. also revealed the pmenceof distinct 11.-6 species. similar -sw--t-t. 3A. lane 2).
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DISCUSSION
In this report. we show that IL-119 indum IL-6 production in peripheral blood monocytes. Supernatants of IL-113-induced monocyte populations supported the growth of an IL-6-dependent murine hybridoma cell line. €39. and enhanced the proliferation of ERV-infected R cells. Roth of these biologic activities. previously ascribed to human IL-6. were neutralired by antibodies r a i d against purified E coliderived IL-6. In addition. 11.4 species could be specifia l l y immunoprecipitated from '%-lablcd supernatants of Il.-IB-induccd monocytes.
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IL-1 INDUCES IL-6 PRODUCTION IN MONOCYTES

1309
IL-6 in monocyte preparations. LPS, an excellent inducer of IL-6 in human monocytes that could have contaminated E coli-derived material, was either absent or present in concentrations too low to account for the results. In addition, an antibody to highly purified IL-18, but not a control antibody, inhibited the capacity of this IL-18 preparation to induce IL-6 secretion in monocyte preparations.
There is evidence that IL-18 acts on monocytes rather than on contaminant cell populations to induce IL-6 production. First, among PBMC, monocytes represent the principal source of IL-6.24v26s32 Second, we have found that highly purified blood monocytes, but not monocyte-depleted mononuclear cells, produce abundant IL-6 activity upon IL-1 stimulation.
A variety of stimuli are known to induce IL-6 production. Endotoxin is a strong inducer of IL-6 in human fibroblast and monocyte Infection with several RNA-and DNA-containing viruses is associated with IL-6 production in TNF, platelet-derived growth factor, and 81-interferon also induce IL-6 in IL-1 promotes IL-6 production in human fibroblasts, endothelial cells, and keratin~cytes.l~-'~ However, the role of IL-1 as an inducer of IL-6 in monocytes has been A previous study reported that natural IL-18 was a poor inducer of IL-6 in human monocytes that were found to constitutively secrete significant levels of IL-6 activity." When cultured in serumfree medium, as shown in this report, monocytes secrete very little IL-6. This suggests that "constitutive" IL-6 production in monocyte cultures derives from in vitro exposure to IL-6-inducing signals; monocytes already activated by these signals may be refractory to further stimulation with IL-1. It is also possible that the failure to detect IL-18 induction of IL-6 may reflect the state of maturation of the target cells, because, unlike monocytes, macrophages have been reported not to secrete IL-6 in response to IL-18.37 When compared with LPS a t optimal concentrations, we found that human IL-18 a t 10 to 100 ng/mL is an equally potent inducer of IL-6. In addition, as judged by SDS-PAGE in reducing conditions, IL-6 induced by IL-1 in monocytes has a similar degree of heterogeneity to that of IL-6 induced by LPS in the same cells.
IL-la, not used in the present experiments, was reported in one study not to induce IL-6 gene expression in peripheral blood monocytes,21 and, in a contrasting study, was reported to be a good inducer of IL-6 gene in the same cell population.22
While I L -l a and 8 have been reported to use a single type of plasma membrane re~eptor,~' further studies will be necessary to clarify the role of I L -l a as an inducer of IL-6 in monocytes.
Over the last 2 years, we have learned a great deal about the structure and biologic activity of IL-6 in experimental conditions, and we are beginning to understand its role in Nonetheless, we know little about IL-6 interactions with other cytokines also involved in the regulation of acute responses and in the growth and differentiation of cells of the immune and hematopoietic systems. Within this cytokine network, we now know that IL-1 and TNF act as inducers of IL-6 gene expression in a variety of cell type^.^,^,'',^^ We also know that IL-6 cooperates with IL-1 for stimulation of T cells and thymocyte^.'^.^^.^^ Alone, IL-6 can act as a cytokine inducer promoting secretion of IL-2 and perhaps of other autocrine T-cell growth f a~t o r s . '~.~~ Future studies will amplify our knowledge of how IL-6 fits in the cytokine network. The finding reported here, that IL-1 is a potent inducer of IL-6 in monocytes, provides the basis for a better understanding of how these interactive cytokines act individually and in concert to mediate monocyte-derived functions.
